NCT05477160 - A Study of STAR-0215 in Healthy Adult Participants | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 27, 2022

Primary Completion Date

November 17, 2023

Study Completion Date

November 17, 2023

Conditions

Hereditary Angioedema

Interventions

DRUG

STAR-0215 (SC)

STAR-0215 will be administered as an SC bolus injection.

DRUG

Placebo (SC)

Placebo will be administered as an SC bolus injection.

DRUG

STAR-0215 (IV)

STAR-0215 will be administered as an IV bolus injection.

DRUG

Placebo (IV)

Placebo will be administered as an IV bolus injection.

Trial Locations (1)

Spaulding Clinical Research, LLC, West Bend